A study of JYP0035 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called JYP0035 alone in people with advanced solid tumors. It aims to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old
- You must have advanced cancer that has spread or cannot be removed
- You must be healthy enough to perform daily tasks with little to no help (ECOG score 0 or 1)
- You must not have other active cancers or serious heart problems
- You must not have diabetes (type 1 or 2) or had it before
- Women who could become pregnant must have a negative pregnancy test and use birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new investigational drug (JNJ-87890387) for people with certain advanced solid tumors that have spread or cannot be removed by surgery. It aims to see if the drug is safe and effective.
This study tests a new experimental drug (called SYS6051) in people with advanced solid tumors that have not responded to standard treatments. The goal is to find out if the drug is safe and how well it works, and it might help control your cancer.
This early-phase trial tests a new drug (CD-001) for people with advanced solid tumors. It will check if the drug is safe, how the body handles it, and if it helps shrink tumors.
This trial tests a new drug called JYP0015 for people with advanced solid tumors that have a specific change in the RAS gene. It aims to see if the drug can help when other treatments have stopped working or caused too many side effects.
This study tests a new drug called JY016 for people with advanced solid tumors that have a protein called EGFR on their surface. The drug aims to help the immune system attack the cancer cells. It may be an option if standard treatments have stopped working or aren't suitable.
This trial tests an experimental drug called JYP0322 for people with advanced solid tumors that have a specific genetic change called a ROS1 fusion. The goal is to see if the drug is safe and effective against these tumors.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.